InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
January 31, 2022 07:05 ET
|
OraSure Technologies, Inc.
Data Demonstrates InteliSwab® is Accurate, Easy to Use, and Well Accepted by Children BETHLEHEM, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader...
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
January 25, 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
January 13, 2022 16:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 13, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Technologies Announces Actions to Enhance Stockholder Value
January 05, 2022 07:05 ET
|
OraSure Technologies, Inc.
Provides Preliminary 4Q21 Financial OutlookCommences Review of Strategic AlternativesAnnounces Transition of CEO and Organizational ChangesBETHLEHEM, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) -- OraSure...
OraSure Technologies Announces 2022 Annual Meeting Date
December 14, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT...
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus
November 30, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 30, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, today announced its plans for World AIDS Day. Commemorated...
OraSure Technologies to Present at Upcoming Investor Conferences
November 19, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 19, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and...
OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary
November 09, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Technologies Appoints Two New Members to the Board of Directors
November 08, 2021 07:05 ET
|
OraSure Technologies, Inc.
New Appointments Bring to the Company Significant Executive Leadership, Global Product Development, Public Health, and the Retail Pharmacy Market Experience BETHLEHEM, Pa., Nov. 08, 2021 (GLOBE...
OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22
November 03, 2021 16:05 ET
|
OraSure Technologies, Inc.
Third quarter revenue of $53.9 million grew 12% year-over-year; excluding COVID-19 product revenues, revenues for the quarter grew 37% from the prior year, demonstrating strong growthOraSure signs...